Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Orlandi

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Medical Oncology (Northwood, London, England)|February 29, 2020
Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancerDaniela Gentile, Paola Orlandi, Marta Banchi, et al.
Frontiers in Oncology|December 5, 2019
Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer CellsTeresa Di Desidero, Paola Orlandi, Daniela Gentile, et al.
Neuroimage|December 14, 2005
Semantic relevance explains category effects in medial fusiform gyriAndrea Mechelli, Giuseppe Sartori, Paola Orlandi, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 10, 2025
GABAergic signaling in colorectal cancer: Mechanistic insights, tumor microenvironment crosstalk, and therapeutic opportunitiesDonghao Tang, Paola Orlandi, Qijie Li, et al.
Current Oncology Reports|March 6, 2024
Metronomic Chemotherapy in Elderly PatientsArianna Bandini, Pasquale Fabio Calabrò, Marta Banchi, et al.
Oncology Research|January 22, 2017
Simultaneous, But Not Consecutive, Combination With Folinate Salts Potentiates 5-Fluorouracil Antitumor Activity In Vitro and In VivoAntonello Di Paolo, Paola Orlandi, Teresa Di Desidero, et al.
Biochemical Pharmacology|April 17, 2018
Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFR<sup>L858R/T790M</sup> cells to reversible EGFR tyrosine kinase inhibitorsPaola Orlandi, Teresa Di Desidero, Giada Salvia, et al.
In Vivo (Athens, Greece)|January 16, 2014
A new biometric tool for three-dimensional subcutaneous tumor scanning in miceGuido Bocci, Franco Buffa, Bastianina Canu, et al.
Scientific Reports|April 2, 2025
Synergistic activity of tafasitamab and metronomic chemotherapy on diffuse large B-cell lymphoma through inhibition of the AKT/mTOR signaling pathwayMarta Banchi, Maria Christina Cox, Paola Orlandi, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic ApproachPaola Orlandi, Anna Solini, Marta Banchi, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Medical Oncology (Northwood, London, England)|February 29, 2020
Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancerDaniela Gentile, Paola Orlandi, Marta Banchi, et al.
Frontiers in Oncology|December 5, 2019
Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer CellsTeresa Di Desidero, Paola Orlandi, Daniela Gentile, et al.
Neuroimage|December 14, 2005
Semantic relevance explains category effects in medial fusiform gyriAndrea Mechelli, Giuseppe Sartori, Paola Orlandi, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 10, 2025
GABAergic signaling in colorectal cancer: Mechanistic insights, tumor microenvironment crosstalk, and therapeutic opportunitiesDonghao Tang, Paola Orlandi, Qijie Li, et al.
Current Oncology Reports|March 6, 2024
Metronomic Chemotherapy in Elderly PatientsArianna Bandini, Pasquale Fabio Calabrò, Marta Banchi, et al.
Oncology Research|January 22, 2017
Simultaneous, But Not Consecutive, Combination With Folinate Salts Potentiates 5-Fluorouracil Antitumor Activity In Vitro and In VivoAntonello Di Paolo, Paola Orlandi, Teresa Di Desidero, et al.
Biochemical Pharmacology|April 17, 2018
Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFR<sup>L858R/T790M</sup> cells to reversible EGFR tyrosine kinase inhibitorsPaola Orlandi, Teresa Di Desidero, Giada Salvia, et al.
In Vivo (Athens, Greece)|January 16, 2014
A new biometric tool for three-dimensional subcutaneous tumor scanning in miceGuido Bocci, Franco Buffa, Bastianina Canu, et al.
Scientific Reports|April 2, 2025
Synergistic activity of tafasitamab and metronomic chemotherapy on diffuse large B-cell lymphoma through inhibition of the AKT/mTOR signaling pathwayMarta Banchi, Maria Christina Cox, Paola Orlandi, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic ApproachPaola Orlandi, Anna Solini, Marta Banchi, et al.
Pageof 7